All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, ...

Based on the progress and results obtained in the first nine months of 2024, BioPorto maintains its financial guidance for 2024, as most recently described in its Interim Report for the Second Quarter ...

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?